Skip to content

Clinical Study for the Therapeutic Effect of Acupuncture on Pseudomyopia in children and its influence on Choroid and Retina

Clinical Study for the Therapeutic Effect of Acupuncture on Pseudomyopia in children and its influence on Choroid and Retina

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041735
Enrollment
Unknown
Registered
2021-01-03
Start date
2020-12-31
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pseudomyopia

Interventions

experimental group:Acupuncture
control group:N/A

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 7 to 12 years, male or female; 2.Patients who meet the diagnostic criteria of myopia in children 3.Patients with good compliance who volunteers to join the subject and signs informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with other ocular diseases(e.g., cataract, congenital retinal disease, strabismus, amblyopia); 2.Patients with active eye lesions or undergo eye surgery; 3.Patients with systemic diseases; 4.Patients with mixed myopia; 5.Patients who have used orthokeratology lenses in 3 months; 6.Participants who have used myopia prevention and control drugs (such as atropine). 7.Participants who cannot cooperate with the treatment. 8.Participants whose Guardians have unreasonable expectations.

Design outcomes

Primary

MeasureTime frame
vision;diopter;

Secondary

MeasureTime frame
axial length;choroid thickness;retinal blood flow;accommodative amplitude;visual fatigue;

Countries

China

Contacts

Public ContactFeng Zhao

Shanghai University of Traditional Chinese Medicine

doczhaofeng@163.com+86 13671818162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026